PathoGenesis other research news

Mycobacterium tuberculosis becomes resistant to the anti-tubercular drug isoniazid by eliminating an enzyme, KatG. The loss is paradoxical because the enzyme appears to be crucial for the microbe's survival. However, PGNS researchers have discovered that another enzyme is overproduced to compensate. ...